Abstract
Objective
Opportunistic infections may affect the oral mucosa of patients undergoing radio/chemotherapy through exacerbation of oral mucositis. The aim of this study is to evaluate the oral shedding of all eight human herpesviruses and its possible association with oral mucositis.
Materials and methods
In this prospective cohort study, we analyzed oral rinse samples, collected weekly, from 20 patients during radiotherapy treatment. Serologic status to HSV1 and HSV2, EBV, CMV, and VZV in three different periods was performed by ELISA assay. PCR and enzymatic digestion was performed to detect HSV1, HSV2, EBV, CMV, VZV, HHV6, HHV7, and HHV8. Oral mucositis was evaluated according to the WHO criteria.
Results
Oral shedding of EBV, HHV6, and HHV7 was observed in all weeks of radiotherapy. Considering the episodes of shedding, the highest frequency was found in patients with EBV excretion (55.0%). No virus reactivation was observed by serological analysis. EBV oral shedding frequency was significantly higher than that of other viruses and showing a positive correlation with oral mucositis grade ≥2.
Conclusions
There was a positive correlation between EBV oral shedding and oral mucositis grade ≥2, particularly after 3 weeks of radiotherapy, a period in which the severity of mucositis was statistically higher. These findings allow us to infer that the local inflammatory environment in mucositis grade ≥2 is more favorable for EBV replication.
Clinical relevance
Mucositis is a frequent and important side effect of radio/chemotherapy treatment. Understanding the possible participation of viruses in the mechanism of this condition is important to develop strategies for treatment and prevention.
Similar content being viewed by others
References
Johansson J, Blomquist E, Montelius A, Isacsson U, Glimelius B (2004) Potential outcomes of modalities and techniques in radiotherapy for patients with hypopharyngeal carcinoma. Radiother Oncol 72(2):129–138
Fang FM, Chien CY, Tsai WL, Chen HC, Hsu HC, Lui CC et al (2008) Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy—a longitudinal study. Int J Radiat Oncol Biol Phys 72(2):356–364. doi:10.1016/j.ijrobp.2007.12.054
Parvathaneni U, Laramore GE, Liao JJ (2012) Technical advances and pitfalls in head and neck radiotherapy. J Oncol 2012:597467. doi:10.1155/2012/597467
Jensen AB, Hansen O, Jorgensen K, Bastholt L (1994) Influence of late side-effects upon daily life after radiotherapy for laryngeal and pharyngeal cancer. Acta Oncol 33(5):487–491
Andrews N, Griffiths C (2001) Dental complications of head and neck radiotherapy: part 1. Aust Dent J 46(2):88–94 Review
Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M et al (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100(9 Suppl):1995–2025 Review
Scully C, Epstein J, Sonis S (2004) Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy. Part 2: diagnosis and management of mucositis. Head Neck 26(1):77–84
Lalla RV, Sonis ST, Peterson DE (2008) Management of oral mucositis in patients with cancer. Dent Clin N Am 52(1):1–17 viii
Mosel DD, Bauer RL, Lynch DP, Hwang ST (2011) Oral complications in treatment of cancer patients. Oral Dis 17(6):550–559. doi:10.1111/j.1001-0825.20011.01788.x
Chen Y-K, Hou H-A, Chow J-M, Chen Y-C, Hsueh P-R, Tien H-F (2011) The impact of oral herpes simplex virus infection and candidiasis on chemotherapy-induced oral mucositis among patients with hematological malignancies. Eur J Clin Microbiol Infect Dis 30(6):753–759. doi:10.1007/s10096-010-1148-z
Gouveia de Lima A, Villar RC, de Castro G Jr, Antequera R, Gil E, Rosalmeida MC, MHH F, IML S (2012) Oral mucositis prevention by low-laser therapy in head and neck cancer patients undergoing concurrent Chemoradiotherapy: a phase III randomized study. Int J Radiat Oncol Biol Phys 82(1):270–275. doi:10.1016/j/ijrobp.2010.10.012
Van der Beek MT, Laheij AM, Raber-Durlacher JE, von dem Borne PA, Wolterbeek R, van der Blij-de Brouwer CS et al (2012) Viral loads and antiviral resistance of herpesviruses and oral ulcerations in hematopoietic stem cell transplant recipients. Bone Marrow Transplant 47(9):1222–1228. doi:10.1038/bmt.2012.2
Moslemi D, Nokhandani AM, Otaghsaraei MT, Moghadamnia Y, Kazemi S, Moghadamnia AA (2016) Management of chemo/radiation-induced oral mucositis in patients with head and neck cancer: a review of the current literature. Radiother Oncol. doi:10.1016/j.radonc.2016.04.001
Zanin T, Zanin F, Carvalhosa AA, Castro PHS, Pachec MT, Zanin ICJ et al (2010) Use of 660-nm diode laser in prevention and treatment of human oral mucositis induced by radiotherapy and chemotherapy. Photomed Laser Surg 28(2):233–237. doi:10.1089/pho.2008.2242
Tolentino ES, Centurion BS, Ferreira LHC, Souza AP, Damante JH, Rubira-Bullen IRF (2011) Oral adverse effects of head and neck radiotherapy: literature review and suggestion of a clinical oral care guideline for irradiated patients. J Appl Oral Sci 19(5):448–454 Review
Melkos AB, Massenkeil G, Arnold R, Reichart PA (2003) Dental treatment prior to stem cell transplantation and its influence on the post transplantation outcome. Clin Oral Investig 7(2):113–115
Roizman B (1993) The family Herpesviridae. In: Whitley RJ, Lopez C (eds) The human herpesviruses. Raven Press, New York, pp 1–9
Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM et al (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’ s sarcoma. Science 266(5192):1865–1869
Johnson G, Nelson S, Petric M, Tellier R (2000) Comprehensive PCR-based assay for detection and species identification of human herpesviruses. J Clin Microbiol 38(9):3274–3279
Wagner EK (1994) The herpes simplex type 1 virus latency gene. In: Becker Y, Darai D (eds) Pathogenicity of human herpes viruses due to specific pathogenicity genes. Springer-Verlag, Berlin, pp 210–221
Oakley C, Epstein JB, Sherlock CH (1997) Reactivation of oral herpes simplex virus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 84(3):272–278 Review
Sonis ST (2002) The biologic role for nuclear factor-kappaB in disease and its potential involvement in mucosal injury associated with anti-neoplasic therapy. Crit Rev Oral Biol Med 13(5):380–389
Redding SW, Luce EB, Boren MW (1990) Oral herpes simplex virus infection in patients receiving head and neck radiation. Oral Surg Oral Med Oral Pathol 69(5):578–580
Nicolatou-Galitis O, Dardoufas K, Markoulatos P, Sotiropoulou-Lontou A, Kyprianou K, Kolitsi G et al (2001) Oral pseudomembranous candidiasis, herpes simplex virus-1 infection, and oral mucositis in head and neck cancer patients receiving radiotherapy and granulocyte-macrophage colony-stimulating factor (GM-CSF) mouthwash. J Oral Pathol Med 30(8):471–480
Epstein JB, Gorsky M, Hancock P, Peters N, Sherlock CH (2002) The prevalence of herpes simplex virus shedding and infection in the oral cavity of seropositive patients undergoing head and neck radiation therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 94(6):712–716
Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK et al (2003) Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 66(3):253–262 Review
Nicolatou-Galitis O, Athanassiadou P, Kouloulias V, Sotiropoulou-Lontou A, Dardoufas K, Polychronopoulou A et al (2006) Herpes simplex virus-1 (HSV-1) infection in radiation-induced oral mucositis. Support Care Cancer 14(7):753–762
Correia AVL, Coelho MRCD, de Oliveira Mendes Cahú GG, Almeida Silva JL, da Mota Vasconcelos Brasil C, de Castro JFL (2015) Seroprevalence of HSV1-2 and correlation with aggravation of oral mucositis in patients with squamous cell carcinoma of the head and neck region submitted to antineoplasic treatment. Support Care Cancer 23(7):2105–2111. doi:10.1007/s00520-014-2558-8
Anonymous (1995) The world health organization quality of life assessment (WHOQOL): position paper from the world health organization. Soc Sci Med 41(10):1403–9
Rüping MJ, Keulertz C, Vehreschild JJ, Lövenich H, Söhngen D, Wieland U, Cornely OA (2011) Association of HSV reactivation and pro-inflammatory cytokine levels with the severity of stomatitis after BEAM chemotherapy and autologous SCT. Support Care Cancer 19(8):1211–1216. doi:10.1007/s00520-010-0940-8
Carvalho RR, de Paula EF, Ramalho KM, Antunes JL, Bezinelli LM, de Magalhães MH et al (2010) Effect of laser phototherapy on recurring herpes labialis prevention: an in vivo study. Lasers Med Sci 25(3):397–402. doi:10.1007/s10103-009-0717-9
Bello-Silva MS, de Freitas PM, Aranha AC, Lage-Marques JL, Simões A, de Paula Eduardo C (2010) Low- and high-intensity lasers in the treatment of herpes simplex virus 1 infection. Photomed Laser Surg 28(1):135–139. doi:10.1089/pho.2008.2458
Eduardo Cde P, Bezinelli LM, Eduardo Fde P, da Graça Lopes RM, Ramalho KM, Bello-Silva MS et al (2012) Prevention of recurrent herpes labialis outbreaks through low-intensity laser therapy: a clinical protocol with 3-year follow-up. Lasers Med Sci 27(5):1077–1083. doi:10.1007/s10103-611-1019-6
Muñoz Sanchez PJ, Capote Femenías JL, Díaz Tejeda A, Tunér J (2012) The effect of 670-nm low laser therapy on herpes simplex type 1. Photomed Laser Surg 30(1):37–40. doi:10.1089/pho.2011.3076
de Paula Eduardo C, Aranha AC, Simões A, Bello-Silva MS, Ramalho KM, Esteves-Oliveira M et al (2014) Laser treatment of recurrent herpeslabialis: a literature review. Lasers Med Sci 29(4):1517–1529. doi:10.1007/s10103-01301311
Dougal G, Lee SY (2003) Evaluation of the efficacy of low-level light therapy using 1072 nm infrared light for the treatment of herpes simplex labialis. Clin Exp Dermatol 38(7):713–718. doi:10.1111/ced.12069
Stona P, da Silva VE, Dos Santos Pires L, Blessmann Weber JB, Floriani Kramer P (2014) Recurrent labial herpes simplex in pediatric dentistry: low-level laser therapy as a treatment option. Int J Clin Pediatr Dent 7(2):140–143. doi:10.5005/jp-journals-10005-1252
Ward K (2005) The natural history and laboratory diagnosis of human herpesviruses-6 and -7 infections in the immunocompetent. J Clin Virol 32(3):183–193 Review
Biganzoli P, Ferreyra L, Sicilia P, Carabajal C, Frattari S, Littvik A et al (2010) IgG subclasses and DNA detection of HHV-6 and HHV-7 in healthy individuals. J Med Virol 82(10):1679–1683. doi:10.1002/jmv.21.880
Magalhães IM, Martins R, Cossatis JJ, Cavaliere RM, Afonso LA, Moyses N et al (2010) Detection of human herpesvirus 6 and 7 DNA in saliva from healthy adults from Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz 105(7):925–927
Pinheiro RS, Ferreira DC, Nobrega F, Santos NS, Souza IP, Castro GF (2013) Current status of herpesvirus identification in the oral cavity of HIV-infected children. Rev Soc Bras Med Trop 46(1):15–19
Yamamoto Y, Morooka M, Hashimoto S, Ihra M, Yoshikawa T (2014) Analysis of the shedding of three β-herpesviruses in urine and saliva of children with renal disease. J Med Virol 86(3):505–511. doi:10.1002/jmv.23782
Ambinder RF, Wingard JR, Burns WH, Hayward SD, Saral R, Perry HR et al (1985) Detection of Epstein-Barr virus DNA in mouthwashes by hybridization. J Clin Microbiol 21(3):353–356
Braz-Silva PH, Ortega KL, Rezende NP, Nunes FD, Magalhães MH (2006) Detection of Epstein-Barr virus (EBV) in the oral mucosa of renal transplant patients. Diagn Cytopathol 34(1):24–28
Tsao SW, Tsang CM, Pang PS, Zhang G, Chen H, Lo KW (2012) The biology of EBV infection in human epithelial cells. Semin Cancer Biol 22(2):137–143 Review
Seoudi N, Bergmeier LA, Hagi-Pavli E, Bibby D, Fortune F (2015) The seroprevalence and salivary shedding of herpesviruses in Behçet’s syndrome and recurrent aphthous stomatitis. J Oral Microbiol 5(7):27156. doi:10.3402/jan.v7.27156.eCollection
Mohammed FF, Poon I, Zhang L, Elliott L, Hodson ID, Sagar SM et al (2012) Acute-phase response reactants as objective bio- markers of radiation-induced mucositis in head and neck cancer. Head Neck 34(7):985–993. doi:10.1002/hen.21848
Krause CE, Otieno BA, Bishop GW, Phadke G, Choquette L, Lalla RV et al (2015) Ultrasensitive microfluidic array for serum pro-inflammatory cytokines and C-reactive protein to assess oral mucositis risk in cancer patients. Anal Bioanal Chem 407(23):7239–7243. doi:10.1007/s00216-015-8873-1
Acknowledgements
The authors would like to thank financial support from Conselho Nacional de Desenvolvimento Tecnológico (CNPq; grant no. 443004/2014-5 and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; grants no. 2012/04303-5 and no. 2015/03906-6.)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Palmieri, M., Martins, V.A.d.O., Sumita, L.M. et al. Oral shedding of human herpesviruses in patients undergoing radiotherapy/chemotherapy treatment for head and neck squamous cell carcinoma. Clin Oral Invest 21, 2291–2301 (2017). https://doi.org/10.1007/s00784-016-2022-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00784-016-2022-x